GlassScriptPhysician profile
Roberto I Gonzalez
NPI 1891159349
$3,244.88
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $238 · 2021: $1,167 · 2022: $741 · 2023: $426 · 2024: $389 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980 · Education: $14.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.26 |
| Education | $14.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $703.86 | 2021-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $596.26 | 2020-2022 | |
| Novo Nordisk INC | $555.25 | 2021-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $313.68 | 2021-2025 | Mounjaro, Jardiance |
| Abbott Laboratories | $228.46 | 2020-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $166.39 | 2022-2024 | Tymlos |
| Insulet Corporation | $122.70 | 2021-2023 | Omnipod |
| Janssen Pharmaceuticals, INC | $107.86 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $103.34 | 2019 | |
| Inspire Medical Systems, INC. | $76.98 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.84 | 2024-2025 | Jardiance, Spiriva Respimat |
| Bayer Healthcare Pharmaceuticals INC. | $53.75 | 2021-2022 | |
| Corcept Therapeutics | $44.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.89 | 2022-2023 | |
| Pfizer INC. | $26.81 | 2023-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.74 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.76 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.